严重维生素D缺乏是自身免疫性肝炎的预后生物标志物
该研究在209例自身免疫性肝炎(AIH)患者中评估严重维生素D缺乏(血清<25 nmol/L)的频率及其与治疗无应答、肝相关死亡或需肝移植的关系。结果显示严重缺乏者治疗无应答更常见(59% vs 41%,P=0.04),且独立关联肝硬化风险(HR 3.40)及肝相关死亡或需肝移植风险(HR 5.26)。补充后持续严重缺乏者预后仍差。
要点
- 42例(20%)AIH患者存在严重维生素D缺乏(血清<25 nmol/L)。
- 严重缺乏者治疗无应答比例59% vs 41%(P=0.04)。
- 严重缺乏独立关联肝硬化(HR 3.40)及肝相关死亡或需肝移植(HR 5.26)。
核心结论
- 严重维生素D缺乏与治疗无应答、进展为肝硬化及肝相关死亡或需肝移植相关。
- 严重维生素D缺乏是自身免疫性肝炎的预后生物标志物。
- 补充维生素D后持续严重缺乏的患者预后仍差。
研究设计与样本
- 研究纳入209例自身免疫性肝炎患者,初诊时行肝组织检查。
- 测定血清维生素D水平,<25 nmol/L(10 ng/mL)定义为严重缺乏。
- 治疗无应答定义为常规免疫抑制治疗期间天冬氨酸氨基转移酶/丙氨酸氨基转移酶及免疫球蛋白G水平未正常化。
- 采用二元逻辑回归和Cox比例风险模型进行单因素和多因素分析。
主要发现
- 平均维生素D水平为60 ± 38 nmol/L(范围3-263 nmol/L),42例(20%)存在严重维生素D缺乏。
- 严重维生素D缺乏者治疗无应答更常见:59% vs 41%(P=0.04)。
- 严重维生素D缺乏独立关联肝硬化风险升高(HR 3.40;95%CI 1.30-8.87,P=0.01)。
- 严重维生素D缺乏独立关联肝相关死亡或需肝移植风险升高(HR 5.26;95%CI 1.54-18.0,P=0.008)。
- 补充维生素D后持续严重缺乏的患者预后仍差。
关键数值与推荐
- 严重维生素D缺乏定义为血清维生素D <25 nmol/L(10 ng/mL)。
- 治疗无应答定义为常规免疫抑制治疗期间AST/ALT及IgG水平未正常化。
- 严重维生素D缺乏与肝硬化风险的HR为3.40(95%CI 1.30-8.87,P=0.01)。
- 严重维生素D缺乏与肝相关死亡或需肝移植风险的HR为5.26(95%CI 1.54-18.0,P=0.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitamin D deficiency has been implicated in the outcome of chronic liver disease. AIM: To determine the frequency of severe vitamin D deficiency in autoimmune hepatitis (AIH), assess its association with treatment non-response, and evaluate the relationship between vitamin D status and liver-related mortality and need for transplantation. METHODS: Two hundred and nine patients were evaluated by liver tissue examination at presentation. Serum vitamin D levels were determined, and serum levels <25 nmol/L (10 ng/mL) were considered severely deficient. Treatment non-response was defined as non-normalised aspartate aminotransferase/alanine aminotransferase and immunoglobulin G levels during conventional immunosuppressive therapy. Univariate and multivariate analyses were performed using binary logistic regression and Cox proportional hazards model. RESULTS: The mean vitamin D level was 60 ± 38 nmol/L (range, 3-263 nmol/L), and 42 patients (20%) had severe vitamin D deficiency. Treatment non-response was more common in patients with severe vitamin D deficiency than in patients without (59% vs 41%, P = 0.04). Severe vitamin D deficiency was also independently associated with a higher risk of developing cirrhosis (HR 3.40; 95% CI 1.30-8.87, P = 0.01) and liver-related mortality or requirement for liver transplantation (LT; HR 5.26, 95% CI, 1.54-18.0, P = 0.008). Patients with persistent severe deficiency following vitamin D supplementation continued to have poor outcomes. CONCLUSIONS: Severe vitamin D deficiency is associated with treatment non-response, progression to cirrhosis, and liver-related death or need for LT. Severe vitamin D deficiency is a prognostic biomarker in AIH.
引用
- Ebadi M, Bhanji RA, Mazurak VC, et al. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Aliment Pharmacol Ther. 2018. PMID: 30484857. doi:10.1111/apt.15029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。